A Dexcom spokeswoman said there are already 20,000 Medicare patients in the pipeline with almost no advertisement of the policy change.

Surviving cancer doesn't mean the challenges are all in the past. After cancer is treated and cured, many survivors still face financial debt and lingering toxicities that impact their lives.

A new study indicates that palliative care can significantly reduce end-of-life hospitalizations and aggressive procedures among Medicare beneficiaries with advanced cancer.

With the comment period now concluded, CMS has received nearly 1300 comments on its proposed amendments to the Quality Payment Program established by the Medicare Access and CHIP Reauthorization Act (MACRA).

Two Harvard health experts take an in-depth look at who benefits from Medicaid: children and the elderly consume the vast majority of the dollars spent.

According to a new study published in Cancer, an annual screening mammogram starting at age 40 has the greatest impact on reducing mortality.

Probiotics are often believed to stimulate healthy immune function, but a new study did not find significant evidence that a supplement of lactobacillus prevents eczema, which is a common precursor to asthma.

A one-size-fits-all approach to value is impossible in the US healthcare system, but a pluralistic approach is extremely complex to implement, says Ilene Hollin, PhD, MPH, the National Pharmaceutical Council and University of Southern California Schaeffer Center’s Postdoctoral Health Policy Fellow.

The American Diabetes Association (ADA) today offered a position statement on treating diabetes and hypertension for the first time since 2003.

A new study indicates that expanded coverage under the Affordable Care Act (ACA) added strain on emergency medical services, resulting in slower ambulance response times.

Children who were obese or at risk of obesity had less activity in the brain's self-regulation centers.

There is more than just genetics to consider when evaluating a person’s health and their potential for developing certain diseases, explained Christos A. Galanopoulos, MD, MBA, MsC, FACS, adjunct professor of the Applied Innovation Center at the Desert Research Institute and co-director of the Renown Institute for Health Innovation at Renown Health.

The overwhelmingly high number of deaths related to chronic obstructive pulmonary disease and asthma—the 2 most common chronic respiratory diseases in the world—call for affordable interventions that have the ability to prevent or treat the severe chronic respiratory burden.